POPADAD trial. Time for a proper study of aspirin after a vascular event?
Cleland
John G F
JG
D001241:Aspirin / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D006801:Humans; D010506:Periodicals as Topic; D016491:Peripheral Vascular Diseases / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin